Physician profile
Michael Adkins
NPI 1609885649
$1,573.52
in general payments reported to CMS, 2019-2025
13 companies · $166 in 2025
The $166 reported for 2025 was less than what a typical Optometrist provider received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $203 · 2020: $50.25 · 2021: $108 · 2022: $198 · 2023: $758 · 2024: $90.41 · 2025: $166.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $592 · Food and Beverage: $423.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $592.49 |
| Food and Beverage | $422.58 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biotissue Holdings INC. | $848.06 | 2019-2025 | |
| Coopervision INC. | $250.21 | 2019-2025 | Myday Contact Lens, Biofinity Contact Lens, Clariti Contact Lens |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $123.96 | 2019-2021 | |
| Bausch & Lomb Americas INC. | $109.50 | 2022-2025 | Infuse, Biotrue One Day |
| Alcon Vision LLC | $51.92 | 2019-2024 | |
| Johnson & Johnson Surgical Vision, INC. | $41.93 | 2019 | |
| Tandem Diabetes Care, INC. | $35.97 | 2025 | T:Slim X2 Insulin Pump With Control-Iq |
| Abbvie INC. | $27.38 | 2022 | |
| Allergan, INC. | $27.14 | 2021 | |
| Dompe US, INC. | $19.80 | 2022 | |
| Johnson & Johnson Vision Care, INC. | $14.63 | 2019 | |
| Kala Pharmaceuticals, INC. | $12.10 | 2021 | |
| Optos, INC. | $10.92 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Adkins listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.